These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 33353723)
41. Impaired attention function based on the Montréal Cognitive Assessment in vascular dementia patients with frontal hypoperfusion: The Osaki-Tajiri project. Akanuma K; Meguro K; Kato Y; Takahashi Y; Nakamura K; Yamaguchi S J Clin Neurosci; 2016 Jun; 28():128-32. PubMed ID: 26778514 [TBL] [Abstract][Full Text] [Related]
42. Clinical deficits of Alzheimer's disease with cerebrovascular disease and probable VaD. Erkinjuntti T Int J Clin Pract Suppl; 2001 May; (120):14-23. PubMed ID: 11406922 [TBL] [Abstract][Full Text] [Related]
43. Neuroimaging Outcomes in Studies of Cognitive Training in Mild Cognitive Impairment and Early Alzheimer's Disease: A Systematic Review. Beishon L; Intharakham K; Swienton D; Panerai RB; Robinson TG; Haunton VJ Curr Alzheimer Res; 2020; 17(5):472-486. PubMed ID: 32579501 [TBL] [Abstract][Full Text] [Related]
44. Evaluation of choroidal thickness in prodromal Alzheimer's disease defined by amyloid PET. López-de-Eguileta A; Lage C; López-García S; Pozueta A; García-Martínez M; Kazimierczak M; Bravo M; de Arcocha-Torres M; Banzo I; Jimenez-Bonilla J; Cerveró A; Goikoetxea A; Rodríguez-Rodríguez E; Sánchez-Juan P; Casado A PLoS One; 2020; 15(9):e0239484. PubMed ID: 32956392 [TBL] [Abstract][Full Text] [Related]
45. Magnetic Resonance Imaging of Vascular Contributions to Cognitive Impairment and Dementia. Yassi N; Desmond PM; Masters CL J Mol Neurosci; 2016 Nov; 60(3):349-353. PubMed ID: 27437942 [TBL] [Abstract][Full Text] [Related]
46. An Assessment of the Relationship between Structural and Functional Imaging of Cerebrovascular Disease and Cognition-Related Fibers. Tang X; Xiao X; Yin J; Yang T; Zeng B Comput Math Methods Med; 2020; 2020():4347676. PubMed ID: 32411283 [TBL] [Abstract][Full Text] [Related]
47. Optimizing Use of Neuroimaging Tools in Evaluation of Prodromal Alzheimer's Disease and Related Disorders. Raji CA; Torosyan N; Silverman DHS J Alzheimers Dis; 2020; 77(3):935-947. PubMed ID: 32804147 [TBL] [Abstract][Full Text] [Related]
48. MRI and CT in the diagnosis of vascular dementia. van Straaten EC; Scheltens P; Barkhof F J Neurol Sci; 2004 Nov; 226(1-2):9-12. PubMed ID: 15537511 [TBL] [Abstract][Full Text] [Related]
49. The Cingulate Island Sign on FDG-PET vs. IMP-SPECT to Assess Mild Cognitive Impairment in Alzheimer's Disease vs. Dementia with Lewy Bodies. Chiba Y; Fujishiro H; Iseki E; Kasanuki K; Sato K J Neuroimaging; 2019 Nov; 29(6):712-720. PubMed ID: 31199036 [TBL] [Abstract][Full Text] [Related]
50. Feasibility and acceptance of simultaneous amyloid PET/MRI. Schütz L; Lobsien D; Fritzsch D; Tiepolt S; Werner P; Schroeter ML; Berrouschot J; Saur D; Hesse S; Jochimsen T; Rullmann M; Sattler B; Patt M; Gertz HJ; Villringer A; Claßen J; Hoffmann KT; Sabri O; Barthel H Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2236-2243. PubMed ID: 27435367 [TBL] [Abstract][Full Text] [Related]
51. Role of inflammatory markers in the diagnosis of vascular contributions to cognitive impairment and dementia: a systematic review and meta-analysis. Custodero C; Ciavarella A; Panza F; Gnocchi D; Lenato GM; Lee J; Mazzocca A; Sabbà C; Solfrizzi V Geroscience; 2022 Jun; 44(3):1373-1392. PubMed ID: 35486344 [TBL] [Abstract][Full Text] [Related]
52. Vascular dementia: challenge of clinical diagnosis. Erkinjuntti T Int Psychogeriatr; 1997; 9 Suppl 1():51-8; discussion 77-83. PubMed ID: 9447427 [TBL] [Abstract][Full Text] [Related]
53. Impaired cerebral blood flow in type 2 diabetes mellitus - A comparative study with subjective cognitive decline, vascular dementia and Alzheimer's disease subjects. Chau ACM; Cheung EYW; Chan KH; Chow WS; Shea YF; Chiu PKC; Mak HKF Neuroimage Clin; 2020; 27():102302. PubMed ID: 32521474 [TBL] [Abstract][Full Text] [Related]
54. Multi-Parametric Classification of Vascular Cognitive Impairment and Dementia: The Impact of Diverse Cerebrovascular Injury Biomarkers. Lang B; Kindy MS; Kozel FA; Schultz SK; Taheri S J Alzheimers Dis; 2018; 62(1):39-60. PubMed ID: 29439338 [TBL] [Abstract][Full Text] [Related]
55. [Molecular neuroimaging in the study of cognitive impairment: contribution of the cerebral blood flow SPECT with 99mTc-HMPAO and 18F-FDG PET/CT scan]. Banzo I; Quirce R; Martínez-Rodríguez I; Jiménez-Bonilla J; Portilla-Quattrociocchi H; Medina-Quiroz P; Ortega F; Rodríguez E; Mateo I; Vázquez-Higuera JL; de Arcocha M; Carril JM Rev Esp Med Nucl; 2011; 30(5):301-6. PubMed ID: 21640440 [TBL] [Abstract][Full Text] [Related]
56. Clinical Relevance of [ Librizzi D; Cabanel N; Zavorotnyy M; Riehl E; Kircher T; Luster M; Hooshyar Yousefi B Molecules; 2021 Feb; 26(5):. PubMed ID: 33652938 [TBL] [Abstract][Full Text] [Related]
57. Integrated Positron Emission Tomography/Magnetic Resonance Imaging in clinical diagnosis of Alzheimer's disease. Gao F Eur J Radiol; 2021 Dec; 145():110017. PubMed ID: 34826792 [TBL] [Abstract][Full Text] [Related]
58. MRI, CT, SPECT, PET: their use in diagnosing dementia. Jagust WJ; Eberling JL Geriatrics; 1991 Feb; 46(2):28-35. PubMed ID: 1991619 [TBL] [Abstract][Full Text] [Related]
59. The Whole Picture: From Isolated to Global MRI Measures of Neurovascular and Neurodegenerative Disease. Dickie DA; Quinn TJ; Dawson J Adv Exp Med Biol; 2019; 1205():25-53. PubMed ID: 31894568 [TBL] [Abstract][Full Text] [Related]
60. Vascular Burden Score Impacts Cognition Independent of Amyloid PET and MRI Measures of Alzheimer's Disease and Vascular Brain Injury. DeCarli C; Villeneuve S; Maillard P; Harvey D; Singh B; Carmichael O; Fletcher E; Olichney J; Farias S; Jagust W; Reed B; Mungas D J Alzheimers Dis; 2019; 68(1):187-196. PubMed ID: 30775991 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]